Stocks and Investing
Stocks and Investing
Tue, January 30, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, January 29, 2018
[ 12:00 AM ] - United States, WOPRAI
Geoffrey Porges Downgraded (ABBV) to Hold on, Jan 29th, 2018
Geoffrey Porges of Leerink Swann, Downgraded "AbbVie Inc." (ABBV) to Hold on, Jan 29th, 2018.
Geoffrey has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 3 agree with Geoffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Alex Arfaei of "BMO Capital" Maintained at Hold with Increased Target to $84 on, Thursday, November 16th, 2017
- Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017
- Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
This is the rating of the analyst that currently disagrees with Geoffrey
- Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017
Contributing Sources